The New York Times reports Goldman Sachs is requiring employees to report their COVID-19 vaccination status and type of vaccine received as part of its return-to-office planning. The bank previously made vaccine disclosures optional. "Registering your vaccination status allows us to plan for a safer return to the office for all of our people as we continue to abide by local public health measures," Goldman said in a memo to employees. Editor's note: IAPP Staff Writer Jennifer Bryant previously wrote about privacy concerns associated with companies' return-to-office planning.
If you want to comment on this post, you need to login.